Macquarie Group’s Foundation Medicine, Inc. FMI Stock Holding History

Macquarie Group’s Portfolio FMI Stock Details FMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-100,011	Closed	-$13.7M	–	2373
2018 Q2	$13.7M	Sell	100,011 -333	-0.3%	-$30.2K	0.02%	563
2018 Q1	$7.9M	Sell	100,344 -2,464	-2%	-$182K	0.01%	659
2017 Q4	$7.01M	Sell	102,808 -3,795	-4%	-$197K	0.01%	715
2017 Q3	$4.29M	Buy	106,603 +26,603	+33%	+$1.03M	0.01%	790
2017 Q2	$3.18M	Hold	80,000	–	–	0.01%	853
2017 Q1	$2.58M	Hold	80,000	–	–	﹤0.01%	905
2016 Q4	$1.42M	Hold	80,000	–	–	﹤0.01%	1068
2016 Q3	$1.87M	Sell	80,000 -80,000	-50%	-$1.82M	﹤0.01%	975
2016 Q2	$2.99M	Buy	160,000 +60,000	+60%	+$1.08M	﹤0.01%	1044
2016 Q1	$1.82M	Hold	100,000	–	–	﹤0.01%	979
2015 Q4	$2.11M	Buy	100,000 +42,700	+75%	+$823K	﹤0.01%	918
2015 Q3	$1.06M	Buy	57,300 +47,212	+468%	+$1.18M	﹤0.01%	1129
2015 Q2	$341K	Sell	10,088 -49,912	-83%	-$2.01M	﹤0.01%	1360
2015 Q1	$2.89M	Buy	+60,000	New	+$2.72M	0.01%	915

Macquarie Group's FMI Position: Q3 2018 in Review

Macquarie Group sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 100,011 shares — an estimated $13.7M sold.

Macquarie Group first reported a position in FMI in Q1 2015 and held it in 14 quarters. The position peaked at $13.7M in Q2 2018. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.

Macquarie Group reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
Macquarie Group sold 100,011 Foundation Medicine, Inc. shares in Q3 2018, an estimated $13.7M.
Macquarie Group first reported a position in Foundation Medicine, Inc. in Q1 2015 and held it in 14 quarters.
Macquarie Group's Foundation Medicine, Inc. position peaked at $13.7M in Q2 2018.
0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.

Based on Macquarie Group's 13F filing for Q3 2018, filed 15 Nov 2018.